TRASTUZUMAB

trastuzumab 600 mg/5 mL injection, 5 mL vial

TRASTUZUMAB (10817H)

trastuzumab 600 mg/5 mL injection, 5 mL vial
10817H
Body System:
Manner of administration:Injection
Section 100 (CT)
Authority Required (STREAMLINED)

Restriction  9462

Indication: Metastatic (Stage IV) HER2 positive breast cancer
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 3 DPMQ: $1,470.22 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Herceptin SC